India's Metropolis Healthcare hits 5-month high on Q1 revenue growth
** Shares of Metropolis Healthcare METP.NS rise 3.5%, their highest since January 30 ** Co's Q1 consol revenue grew ~23% on Y/Y basis ** Co's revenue, excluding acquisitions, up ~13% Y/Y ** Says growth driven by increase in patient and test volumes, a favourable shift in product mix and improved realizations ** Analysts on average rate the stock "buy"; median PT 1,917.50 rupees, as per data compiled by LSEG ** YTD, METP down 14.6% (Reporting by Yagnoseni Das in Bengaluru) ((Yagnoseni.Das@thomsonreuters.com;))
Recent news on Metropolis Healthcare
See all newsBrief: Metropolis Healthcare Q2fy27 Revenue Grew About 15% Year-On-Year
Brief: Metropolis Health Says Unit Metropolis Quality Solutions Enters Share Subscription And Shareholder's Agreements
Brief: Metropolis Health June-Quarter Consol Net Profit 566.7 Million Rupees
Brief: Metropolis Health Declares 2Nd Interim Dividend Of 1 Rupee Per Share
Brief: Metropolis Health March-Quarter Consol Net Profit 509 Million Rupees